Abbott, AbbVie Win Over Jury In Depakote Birth Defect Row
An Ohio jury on Monday cleared Abbott Laboratories and AbbVie in a mother's failure-to-warn suit blaming her child's birth defects on the companies' epilepsy drug Depakote, following a 13-day trial....To view the full article, register now.
Already a subscriber? Click here to view full article